Fundus autofluorescence in maternally inherited diabetes and deafness: the gold standard for monitoring maculopathy?

Christopher A. Ovens, Kate Ahmad, Clare L. Fraser

Research output: Contribution to journalArticleResearchpeer-review

Abstract

Maternally inherited diabetes and deafness (MIDD) is a mitochondrial disease associated with dysfunction of the retinal pigment epithelium and photoreceptor outer segments in a peri-foveal arrangement. If chorioretinal atrophy develops, patients risk losing vision. We retrospectively analysed three patients with genetically proven MIDD, assessing atrophy size and progression using overlay in photoshop. Patients showed increase in chorioretinal atrophy of 205%, 46% and 34%, respectively. We also found location-specific progression, where hyper-autofluorescent deposits evolved into areas of atrophy. These results support the use of fundus autofluorescence as a valuable tool in monitoring disease progression and providing prognostic information for clinicians and patients.

LanguageEnglish
Number of pages6
JournalNeuro-Ophthalmology
DOIs
Publication statusE-pub ahead of print - 24 Sep 2019

Fingerprint

Atrophy
Mitochondrial Diseases
Vertebrate Photoreceptor Cells
Retinal Pigment Epithelium
Disease Progression
Noninsulin-dependent diabetes mellitus with deafness

Keywords

  • Atrophy
  • fundus autofluorescence
  • maculopathy
  • MIDD

Cite this

@article{c975ab85730644ba850ebe1979eb98b7,
title = "Fundus autofluorescence in maternally inherited diabetes and deafness: the gold standard for monitoring maculopathy?",
abstract = "Maternally inherited diabetes and deafness (MIDD) is a mitochondrial disease associated with dysfunction of the retinal pigment epithelium and photoreceptor outer segments in a peri-foveal arrangement. If chorioretinal atrophy develops, patients risk losing vision. We retrospectively analysed three patients with genetically proven MIDD, assessing atrophy size and progression using overlay in photoshop. Patients showed increase in chorioretinal atrophy of 205{\%}, 46{\%} and 34{\%}, respectively. We also found location-specific progression, where hyper-autofluorescent deposits evolved into areas of atrophy. These results support the use of fundus autofluorescence as a valuable tool in monitoring disease progression and providing prognostic information for clinicians and patients.",
keywords = "Atrophy, fundus autofluorescence, maculopathy, MIDD",
author = "Ovens, {Christopher A.} and Kate Ahmad and Fraser, {Clare L.}",
year = "2019",
month = "9",
day = "24",
doi = "10.1080/01658107.2019.1653935",
language = "English",
journal = "Neuro-Ophthalmology",
issn = "0165-8107",
publisher = "Informa Healthcare",

}

Fundus autofluorescence in maternally inherited diabetes and deafness : the gold standard for monitoring maculopathy? / Ovens, Christopher A.; Ahmad, Kate; Fraser, Clare L.

In: Neuro-Ophthalmology, 24.09.2019.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Fundus autofluorescence in maternally inherited diabetes and deafness

T2 - Neuro-Ophthalmology

AU - Ovens, Christopher A.

AU - Ahmad, Kate

AU - Fraser, Clare L.

PY - 2019/9/24

Y1 - 2019/9/24

N2 - Maternally inherited diabetes and deafness (MIDD) is a mitochondrial disease associated with dysfunction of the retinal pigment epithelium and photoreceptor outer segments in a peri-foveal arrangement. If chorioretinal atrophy develops, patients risk losing vision. We retrospectively analysed three patients with genetically proven MIDD, assessing atrophy size and progression using overlay in photoshop. Patients showed increase in chorioretinal atrophy of 205%, 46% and 34%, respectively. We also found location-specific progression, where hyper-autofluorescent deposits evolved into areas of atrophy. These results support the use of fundus autofluorescence as a valuable tool in monitoring disease progression and providing prognostic information for clinicians and patients.

AB - Maternally inherited diabetes and deafness (MIDD) is a mitochondrial disease associated with dysfunction of the retinal pigment epithelium and photoreceptor outer segments in a peri-foveal arrangement. If chorioretinal atrophy develops, patients risk losing vision. We retrospectively analysed three patients with genetically proven MIDD, assessing atrophy size and progression using overlay in photoshop. Patients showed increase in chorioretinal atrophy of 205%, 46% and 34%, respectively. We also found location-specific progression, where hyper-autofluorescent deposits evolved into areas of atrophy. These results support the use of fundus autofluorescence as a valuable tool in monitoring disease progression and providing prognostic information for clinicians and patients.

KW - Atrophy

KW - fundus autofluorescence

KW - maculopathy

KW - MIDD

UR - http://www.scopus.com/inward/record.url?scp=85073936528&partnerID=8YFLogxK

U2 - 10.1080/01658107.2019.1653935

DO - 10.1080/01658107.2019.1653935

M3 - Article

JO - Neuro-Ophthalmology

JF - Neuro-Ophthalmology

SN - 0165-8107

ER -